MACRA and the Quality Payment Program is not just another Medicare program that can be marginalized or delayed by specialty group interests. It’s federal legislation that can’t be revised or repealed without congressional intervention—and no one in Washington is considering repeal.
MIPS is only the tip of the iceberg in regards to the true impact of MACRA. The final ruling mandates the transition to value based reimbursement with the ultimate goal of getting providers to adopt risk bearing alternative payment models. Our presentation will provide you with a practical understanding of what the transition to value based care will require, and a road map to start planning now to successfully navigate that transformation.